Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

Antibody deficiency is the most frequently encountered primary immunodeficiency disease (PIDD) and patients who lack the ability to make functional immunoglobulin require life-long replacement therapy to prevent serious bacterial infections. Human serum immunoglobulin manufactured from pools of dona...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Skoda-Smith, Suzanne, Torgerson, Troy R, Ochs, Hans D
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2010
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2817783/
https://ncbi.nlm.nih.gov/pubmed/20169031
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller